Skip to main content
Clinical Trials/IRCT2017062434621N1
IRCT2017062434621N1
Recruiting
Phase 3

Effect of prophylactic intracoronary Adenosine infusion during primary percutaneous coronary intervention in Acute ST Elevation Myocardial infarction

Vic-chancellor of Research and Technology, Hamadan University of Medical Sciences0 sites104 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Acute myocardial infarction.
Sponsor
Vic-chancellor of Research and Technology, Hamadan University of Medical Sciences
Enrollment
104
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vic-chancellor of Research and Technology, Hamadan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • (a) ST elevation MI in ECG; (b) LAD and LCX lesion; (c) coronary lesion suitable for angioplasty; (d) TIMI flow 0\-1\.
  • Exclusion criteria: (a) history of COPD or asthma; (b) patients who under treatment with dipyridamol; (c) Presentation with cardiogenic shock; (d) Patients who received fibrynolytic; (e) life expectancy less than 6 month; (f) stent thrombosis; (g) history of CABGs; (h) AV nodal block in first ECG; (I) TIMI flow 2\-3 in angiography; (j) RCA lesion; (k) lack of patient satisfaction.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials